Sign in to view content

2-Year Outcomes From Randomized Trials of Anti-VEGF Treatments for Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

Geeta A. Lalwani, MD

Video
Published 2018

Related

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Annual Meeting Talks
2020
Safety and Efficacy of Retropupillary Iris Claw Intraocular Lens Implant in Aphakia With Inadequate Capsular Support
Aniruddha Maiti, MBBS DO DNB FRVS FICO MRCS FACS FASRS FRCOphth
Annual Meeting Talks
2018
Founders' Award, Playing Your Part in Drug Development, Wiley Chambers, MD
Wiley Chambers, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more